Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 417814, 10 pages
http://dx.doi.org/10.1155/2014/417814
Research Article

Protective Effect of Laminaria japonica with Probiotics on Murine Colitis

1College of Korean Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-701, Republic of Korea
2Acupuncture and Meridian Science Research Center, College of Korean Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-701, Republic of Korea
3Department of Pharmacy, College of Pharmacy, Hanyang University, Ansan 426-791, Republic of Korea

Received 17 January 2014; Accepted 1 May 2014; Published 18 May 2014

Academic Editor: Bing Du

Copyright © 2014 Seok-Jae Ko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Basso, C. F. Zambon, and M. Plebani, “Inflammatory bowel diseases: from pathogenesis to laboratory testing,” Clinical Chemistry & Laboratory Medicine, vol. 52, no. 4, pp. 471–481, 2014. View at Publisher · View at Google Scholar
  2. R. Rahimi, S. Nikfar, and M. Abdollahi, “Induction of clinical response and remission of inflammatory bowel disease by use of herbal medicines: a meta-analysis,” World Journal of Gastroenterology, vol. 14, no. 34, pp. 5738–5749, 2013. View at Google Scholar
  3. R. Rahimi, S. Mozaffari, and M. Abdollahi, “On the use of herbal medicines in management of inflammatory bowel diseases: a systematic review of animal and human studies,” Digestive Diseases & Sciences, vol. 54, no. 3, pp. 471–480, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Rahimi, M. R. Shams-Ardekani, and M. Abdollahi, “A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease,” World Journal of Gastroenterology, vol. 16, no. 36, pp. 4504–4514, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Heo, Donguibogam, Donguibogam Publishing, Seoul, Republic of Korea, 2010.
  6. T. Kuda, T. Fujii Saiheki, A. Hasegawa, and M. Okuzumi, “Effects of brown algae on fecal flora of rat,” Nippon Nogeikagakukaishi, vol. 58, pp. 307–314, 1992. View at Google Scholar
  7. A. Cumashi, N. A. Ushakova, M. E. Preobrazhenskaya et al., “A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds,” Glycobiology, vol. 17, no. 5, pp. 541–552, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. W. Lee, B. Ryu, and J. W. Park, “Effects of sargassum pallidum on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice,” Journal of Korean Oriental Internal Medicine, vol. 31, no. 2, pp. 224–241, 2010. View at Google Scholar
  9. S. Kim, B. Ryu, and J. W. Park, “Effects of Samiunkyuntang on inflammation and fecal enzymes in ulcerative colitis animal model,” Journal of Korean Oriental Medical Society, vol. 29, no. 3, pp. 56–62, 2008. View at Google Scholar
  10. B. J. Lee, “Development of functional food using fermented marine organism,” Food Industry & Nutrition, vol. 18, pp. 8–12, 2013. View at Google Scholar
  11. Y. M. Kang, B. J. Lee, J. I. Kim et al., “Antioxidant effects of fermented sea tangle (Laminaria japonica) by Lactobacillus brevis BJ20 in individuals with high level of γ-GT: a randomized, double-blind, and placebo-controlled clinical study,” Food & Chemical Toxicology, vol. 50, no. 3-4, pp. 1166–1169, 2012. View at Publisher · View at Google Scholar
  12. J. H. Lee, B. Lee, H. S. Lee et al., “Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis,” International Journal of Colorectal Disease, vol. 24, no. 2, pp. 231–237, 2009. View at Google Scholar
  13. A. I. Lee, A. E. Bae, J. H. Lee et al., “Bifidobacterium longum HY8004 attenuates TNBS-induced colitis by inhibiting lipid peroxidation in mice,” Inflammation Research, vol. 59, no. 5, pp. 359–368, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. E. Jang, S. R. Hyam, M. J. Han, S. Y. Kim, B. G. Lee, and D. H. Kim, “Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages,” Journal of Applied Microbiology, vol. 115, no. 3, pp. 888–896, 2013. View at Google Scholar
  15. “Herbal formula and lactic acid bacteria,” http://www.akomnews.com/subpage/search_detail.php?code=A001&uid=53825&page=/subpage/search.php&nowpage=1&search_word.
  16. S. J. Ko, G. Han, S. K. Kim et al., “Effect of Korean herbal medicine combined with a probiotic mixture on diarrhea-dominant irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial,” Evidence-Based Complementary & Alternative Medicine, vol. 2013, Article ID 824605, 10 pages, 2013. View at Publisher · View at Google Scholar
  17. E. O. Petrof, “Probiotics and gastrointestinal disease: clinical evidence and basic science,” Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, vol. 8, no. 3, pp. 260–269, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. B. K. Cha, S. M. Jung, C. H. Choi et al., “The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial,” Journal of Clinical Gastroenterology, vol. 46, no. 3, pp. 220–227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Alex, N. C. Zachos, T. Nguyen et al., “Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis,” Inflammatory Bowel Diseases, vol. 15, no. 3, pp. 341–352, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Johswich, M. Martin, A. Bleich et al., “Role of the C5a receptor (C5aR) in acute and chronic dextran sulfate-induced models of inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 15, no. 12, pp. 1812–1823, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Hyun, P. Andrade-Gordon, M. Steinhoff, and N. Vergnolle, “Protease-activated receptor-2 activation: a major actor in intestinal inflammation,” Gut, vol. 57, no. 9, pp. 1222–1229, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Ryu, W. Ro, J. W. Park et al., “Bojanggunbi-tang, a traditional Korean herbal prescription, ameliorates colonic inflammation induced by dextran sulfate sodium and 2,4,6-trinitrobenzene sulfonic acid in mice,” Journal of Ethnopharmacology, vol. 135, no. 2, pp. 582–585, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. S. J. Suh, U. H. Jin, S. H. Kim et al., “Ochnaflavone inhibits TNF-α-induced human VSMC proliferation via regulation of cell cycle, ERK1/2, and MMP-9,” Journal of Cellular Biochemistry, vol. 99, no. 5, pp. 1298–1307, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. N. A. Molodecky, I. S. Soon, D. M. Rabi et al., “Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review,” Gastroenterology, vol. 142, no. 1, pp. 46–54, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. K. T. Thia, E. V. Loftus Jr., W. J. Sandborn, and S. Yang, “An update on the epidemiology of inflammatory bowel disease in Asia,” The American Journal of Gastroenterology, vol. 103, no. 12, pp. 3167–3182, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. B. E. Sands and S. Grabert, “Epidemiology of inflammatory bowel disease and overview of pathogenesis,” Medicine & Health, Rhode Island, vol. 92, no. 3, pp. 73–77, 2009. View at Google Scholar · View at Scopus
  27. M. Z. Cader and A. Kaser A, “Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation,” Gut, vol. 62, no. 11, pp. 1653–1664, 2013. View at Publisher · View at Google Scholar
  28. S. Kitajima, S. Takuma, and M. Morimoto, “Histological analysis of murine colitis induced by dextran sulfate sodium of different molecular weights,” Experimental Animals, vol. 49, no. 1, pp. 9–15, 2000. View at Google Scholar · View at Scopus
  29. H. S. Cooper, S. N. Murthy, R. S. Shah, and D. J. Sedergran, “Clinicopathologic study of dextran sulfate sodium experimental murine colitis,” Laboratory Investigation, vol. 69, no. 2, pp. 238–250, 1993. View at Google Scholar · View at Scopus
  30. M. Kawada, A. Arihiro, and E. Mizoguchi, “Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease,” World Journal of Gastroenterology, vol. 13, no. 42, pp. 5581–5593, 2007. View at Google Scholar · View at Scopus
  31. F. Loher, C. Bauer, N. Landauer et al., “The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation,” Journal of Pharmacology & Experimental Therapeutics, vol. 308, no. 2, pp. 583–590, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Rachmilewitz, F. Karmeli, K. Takabayashi et al., “Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis,” Gastroenterology, vol. 122, no. 5, pp. 1428–1441, 2002. View at Google Scholar · View at Scopus
  33. B. Egger, M. Bajaj-Elliott, T. T. Macdonald, R. Inglin, V. E. Eysselein, and M. W. Büchler, “Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency,” Digestion, vol. 62, no. 4, pp. 240–248, 2000. View at Google Scholar · View at Scopus
  34. R. Ito, M. Kita, M. Shin-Ya et al., “Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice,” Biochemical & Biophysical Research Communications, vol. 377, no. 1, pp. 12–16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Im, Y. J. Choi, C. Pothoulakis, and S. H. Rhee, “Bacillus polyfermenticus ameliorates colonic inflammation by promoting cytoprotective effects in colitic mice,” Journal of Nutrition, vol. 139, no. 10, pp. 1848–1854, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. S. Kim, M. H. Lee, A. S. Ju, and K. J. Rhee, “Th17 responses are not induced in dextran sodium sulfate model of acute colitis,” Immune Network, vol. 11, no. 6, pp. 416–419, 2011. View at Publisher · View at Google Scholar
  37. I. J. Fuss, C. Becker, Z. Yang et al., “Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody,” Inflammatory Bowel Diseases, vol. 12, no. 1, pp. 9–15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. J. W. Park, H. Bae, G. Lee et al., “Prophylactic effects of Lonicera japonica extract on dextran sulphate sodium-induced colitis in a mouse model by the inhibition of the Th1/Th17 response,” The British Journal of Nutrition, vol. 109, no. 2, pp. 283–292, 2013. View at Publisher · View at Google Scholar
  39. T. L. Denning, Y. Wang, S. R. Patel, I. R. Williams, and B. Pulendran, “Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses,” Nature Immunology, vol. 8, no. 10, pp. 1086–1094, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Yoda, K. Miyazawa, M. Hosoda, M. Hiramatsu, F. Yan, and F. He, “Lactobacillus GG milk prevents DSS-induced colitis and regulates intestinal epithelial homeostasis through activation of epidermal growth factor receptor,” The European Journal of Nutrition, vol. 53, pp. 105–115, 2013. View at Publisher · View at Google Scholar
  41. R. Toumi, K. Abdelouhab, H. Rafa et al., “Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis,” Immunopharmacology & Immunotoxicology, vol. 35, no. 3, pp. 403–409, 2013. View at Publisher · View at Google Scholar
  42. S. Latvala, M. Miettinen, R. A. Kekkonen, R. Korpela, and I. Julkunen, “Lactobacillus rhamnosus GG and Streptococcus thermophilus induce suppressor of cytokine signalling 3 (SOCS3) gene expression directly and indirectly via interleukin-10 in human primary macrophages,” Clinical & Experimental Immunology, vol. 165, no. 1, pp. 94–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. S. G. Jeon, H. Kayama, Y. Ueda et al., “Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon,” PLoS Pathogens, vol. 8, no. 5, Article ID e100271, 2012. View at Google Scholar
  44. M. H. Wu, T. M. Pan, Y. J. Wu, S. J. Chang, M. S. Chang, and C. Y. Hu, “Exopolysaccharide activities from probiotic bifidobacterium immunomodulatory effects (on J774A.1 macrophages) and antimicrobial properties,” International Journal of Food Microbiology, vol. 144, no. 1, pp. 104–110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. P. López, I. González-Rodríguez, B. Sánchez, M. Gueimonde, A. Margolles, and A. Suárez, “Treg-inducing membrane vesicles from Bifidobacterium bifidum LMG13195 as potential adjuvants in immunotherapy,” Vaccine, vol. 30, no. 5, pp. 825–829, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. L. A. Dieleman, M. J. Palmen, H. Akol et al., “Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines,” Clinical & Experimental Immunology, vol. 114, no. 3, pp. 385–391, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. Chinese Pharmacopoeia, Pharmacopoeia Commission of the People's Republic of China Ministry of Health, Joint Publishing, Hongkong, 1991.
  48. Comprehensive Encyclopedia of Science Faculty, Orinetal Medical Dictionary, Ggachi Publishing, Seoul, Republic of Korea, 1990.